Tetrahedron (Leshan) Drug Research

Tetrahedron (Leshan) Drug Research is a Chinese biotechnology company focused on the discovery and development of innovative small molecule therapeutics for metabolic diseases. The company primarily targets conditions such as type 2 diabetes, obesity, and nonalcoholic steatohepatitis (NASH) through the development of next-generation GLP-1 receptor agonists and other metabolic regulators. Tetrahedron (Leshan) leverages its expertise in medicinal chemistry to create optimized drug candidates with improved efficacy and safety profiles. The company's pipeline includes several candidates in various stages of clinical and preclinical development, aiming to address significant unmet needs in the global metabolic health market.